Microorganism |
|
|
|
Antimicrobial |
|
|
Reference |
Proteus (indole-positive) |
0.015 |
2 |
≤0.004 - 64 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
268 |
Proteus (indole-positive) |
0.03 |
0.25 |
0.008 - 0.5 |
Sitafloxacin |
130 |
Proteus (indole-positive) |
0.03 |
0.25 |
0.008 - 0.5 |
Sitafloxacin |
443 |
Proteus (indole-positive) |
0.03 |
1 |
0.008 - 4 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
130 |
Proteus (indole-positive) |
0.03 |
1 |
0.008 - 4 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
443 |
Proteus (indole-positive) |
0.06 |
1 |
0.03 - 2 |
Levofloxacin (Levaquin, Quixin) |
130 |
Proteus (indole-positive) |
0.06 |
1 |
0.03 - 2 |
Levofloxacin (Levaquin, Quixin) |
443 |
Proteus (indole-positive) |
0.06 |
4 |
0.125 - >128 |
Levofloxacin (Levaquin, Quixin) |
268 |
Proteus (indole-positive) |
0.12 |
1 |
0.06 - 1 |
DK-507k |
130 |
Proteus (indole-positive) |
0.12 |
1 |
0.06 - 1 |
DK-507k |
443 |
Proteus (indole-positive) |
0.12 |
2 |
0.03 - 2 |
Gatifloxacin (Tequin) |
443 |
Proteus (indole-positive) |
0.12 |
2 |
0.03 - 2 |
Gatifloxacin (Tequin) |
130 |
Proteus (indole-positive) |
0.12 |
8 |
0.03 - 64 |
Moxifloxacin (BAY 12-8039, Avelox) |
268 |
Proteus (indole-positive) |
0.12 |
8 |
0.03 - >128 |
Gemifloxacin |
268 |
Proteus (indole-positive) |
0.25 |
4 |
0.12 - 4 |
Moxifloxacin (BAY 12-8039, Avelox) |
443 |
Proteus (indole-positive) |
0.25 |
4 |
0.12 - 4 |
Moxifloxacin (BAY 12-8039, Avelox) |
130 |
Proteus (indole-positive) |
0.25 |
4 |
0.25 - 8 |
Garenoxacin (T-3811, BMS-284756) |
130 |
Proteus (indole-positive) |
0.25 |
16 |
0.06 - >128 |
Garenoxacin (T-3811, BMS-284756) |
268 |
Proteus (indole-positive) |
0.5 |
4 |
0.25 - 8 |
Garenoxacin (T-3811, BMS-284756) |
443 |
Proteus (indole-positive) |
0.5 |
8 |
0.03 - 32 |
DC-159a |
268 |
Proteus (indole-positive) |
- |
- |
1.6 - 400 |
Cefamandole (Mandol) |
1418 |
Proteus (indole-positive) |
- |
- |
6.2 - 100 |
Cefoxitin (Mefoxin) |
1418 |
Proteus (indole-positive) |
- |
- |
12.5 - 85 |
Cefuroxime (Kefurox, Zinacef) |
1418 |